“decrease python loop site:vvmgl.com”的搜索结果，显示 261-270 项，共有 7209 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases. Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal ...

2. 传染病- 临床试验- 妙佑医疗国际

   ... for clinical purposes available for this research study. A Study to Evaluate Lamprene (Clofazimine) to Treat Non-Tuberculous Mycobacterial (NTM) Infections.

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Accelerated vs Standard BEP Chemotherapy for ... for epigenetic dysregulation and abnormalities of chromatin and for ... decrease treatment-related side effects, ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to assess tumor cells from blood and bone marrow from patients with myeloid neoplasms for epigenetic dysregulation ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases. Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... for patients with relapsed and refractory multiple myeloma. ... reduce the burden of cancer and improve the quality of life in cancer patients. ... A Study to ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... for children with high-risk neuroblastoma through ... Impact Of Surgical Removal Or Reduction ... The performance characteristics of these assays for ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases. Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...

10. 心血管医学- 临床试验- 妙佑医疗国际

    ... for the first 30 days after hospitalization. Finally, it will allow ... for ticagrelor vs alternative OAP agents, carrying out that descriptive comparison through ...